Search for: "POST PROPERTIES, INC." Results 6781 - 6800 of 9,336
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Dec 2011, 6:20 am by Jeralyn
As the DEA describes it: The DEA set up a bogus money laundering corporation in suburban Miami Lakes that was called Dean International Investments, Inc. [read post]
9 Dec 2011, 11:36 am by escottjohnson
Also according to the blog post, Mr. [read post]
Some investors are buying individual loans and real estate owned (REO) properties taken back by the lender after foreclosure. [read post]
8 Dec 2011, 9:00 pm by Stephanie Figueroa
Prometheus Laboratories Inc., an issue other than whether companies may patent a procedure used in personalized medicine arose. [read post]
8 Dec 2011, 9:00 pm by Stephanie Figueroa
Prometheus Laboratories Inc., an issue other than whether companies may patent a procedure used in personalized medicine arose. [read post]
8 Dec 2011, 10:08 am
Thus, any outstanding debt secured by the property will also remain a [Timberridge Presbyterian Church, Inc.] obligation. [read post]
7 Dec 2011, 6:58 pm by Sean Wajert
Sony Corp. of America Inc., et al., No. 3:10-cv-00795 (S.D. [read post]
7 Dec 2011, 7:40 am by Brian Wm. Higgins
          The National Football League (NFL) Properties, Inc. [read post]
7 Dec 2011, 6:19 am by Nicole Kellner-Swick
  Charges for these actions, including fees for outside counsel for collection actions, civil actions, and post judgment execution, will also be charged to the owner or other responsible party. [read post]
7 Dec 2011, 2:00 am by Steve Lombardi
I ran across several articles posted on the Insurance Journal’s website. [read post]
5 Dec 2011, 8:33 pm by landuseprof
Supreme Court will hear one of the only cases that touches on property rights scheduled for this Term, PPL Montana, Inc., v. [read post]
5 Dec 2011, 3:30 pm by Orin Kerr
(Orin Kerr) In a recently-filed amicus brief submitted by Oracle America Inc. before the en banc Ninth Circuit in United States v. [read post]
5 Dec 2011, 1:41 pm by Ed Wallis
Specifically as to that suit: Ron Leuty wrote in a San Francisco (CA) Business Times (12/2, Subscription Publication) blog posting that “Genentech Inc. will pay $20 million to settle a whistleblower lawsuit around off-label marketing of the cancer-fighting drug Rituxan. [read post]